Patents by Inventor Tao Wang

Tao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10323237
    Abstract: A lysozyme having improved enzymatic activity is disclosed. The amino acid sequence of the lysozyme is a modified amino acid sequence of SEQ ID NO: 2 or a modified amino acid sequence with at least 80% sequence identity of SEQ ID NO: 2, wherein the modification is a substitution of histidine at position 166 or a corresponding position with lysine.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: June 18, 2019
    Assignee: CHENGDU BEACON BIO-TECHNOLOGY CO., LTD.
    Inventors: Chun-Chi Chen, Tao Wang, Jian-Wen Huang, Rey-Ting Guo
  • Publication number: 20190176978
    Abstract: Systems, methods, and devices for propelling self-propelled movable objects are provided. In one aspect, a rotor assembly for a self-propelled movable object comprises: a hub comprising a first fastening feature; a drive shaft comprising a second fastening feature and directly coupled to the hub by a mating connection of the first and second fastening features, wherein the drive shaft is configured to cause rotation of the hub such that the mating connection of the first and second fastening features is tightened by the rotation; and a plurality of rotor blades coupled to the hub and configured to rotate therewith to generate a propulsive force.
    Type: Application
    Filed: December 28, 2018
    Publication date: June 13, 2019
    Inventors: Tao Wang, Tao Zhao, Zhi Gang Ou
  • Publication number: 20190176230
    Abstract: A method and apparatus casts a material with nano-micro duplex grain structure. The apparatus is comprised of module system, heating system, casting mold and gating system, multiaxial compound motion system accompanied by the following technological characteristics; alloy smelting; after heat preservation, alloy melt are poured into the casting mold which is put into the centrifugal barrel of the six-axis motion system; then the casting mold carries out composite motion and the alloy melt starts solidification; as a result, casting Al—Si alloy block with multi-scale nano-structure comprising of nano-micro duplex grain group are prepared. The advantages of the present invention includes that multi-scale casting nano-structure with nano-micro duplex grain group are obtained because of the composite shear flow field generated in the alloy melt.
    Type: Application
    Filed: February 19, 2019
    Publication date: June 13, 2019
    Inventors: Zidong WANG, Tao WANG, Xiaohua CHEN
  • Patent number: 10319942
    Abstract: The present invention provides an OLED device, and a packaging method thereof and a packaging apparatus. The packaging method is for packaging an OLED device formed on a base substrate, and includes: separating a graphene thin film formed on a copper foil from the copper foil; and packaging the OLED device using the graphene thin film. In the packaging method, the graphene thin film is introduced into packaging of an OLED device, thereby not only improving packaging effect of the OLED device, but also simplifying packaging process of the OLED device and increasing production efficiency.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: June 11, 2019
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., ORDOS YUANSHENG OPTOELECTRONICS CO., LTD.
    Inventors: Xiang Feng, Tao Wang, Yun Qiu
  • Patent number: 10316091
    Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: June 11, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton
  • Patent number: 10316090
    Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: June 11, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton
  • Patent number: 10321060
    Abstract: The present invention provides an apparatus and related methods for stabilizing a payload device such an imaging device. The methods and apparatus provide fast response time for posture adjustment of the payload device while reducing the energy used.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: June 11, 2019
    Assignee: SZ DJI OSMO TECHNOLOGY CO., LTD.
    Inventor: Tao Wang
  • Publication number: 20190169257
    Abstract: Provided is an acylated derivative of human insulin or an analogue thereof. Specifically disclosed is an acylated derivative of a human insulin analogue, or zinc complex thereof; said acylated derivative is longer-lasting than existing insulin analogues and acylated derivatives thereof, its blood glucose reduction is more steady, and it is more stable in storage.
    Type: Application
    Filed: August 1, 2017
    Publication date: June 6, 2019
    Applicant: JIANGSU HENGRUI MEDICINE CO., LTD.
    Inventors: Deyu LIU, Hongwei WANG, Liang ZHAO, Feifei WANG, Xiang ZENG, Tao WANG, Yali WANG, Yulu DAI
  • Publication number: 20190174090
    Abstract: Systems and methods can support a data processing apparatus. The data processing apparatus can include a data processor that is associated with a data capturing device on a stationary object and/or a movable object. The data processor can receive data in a data flow from one or more data sources, wherein the data flow is configured based on a time sequence. Then, the data processor can receive a control signal, which is associated with a first timestamp, wherein the first timestamp indicates a first time. Furthermore, the data processor can determine a first data segment by applying the first timestamp on the data flow, wherein the first data segment is associated with a time period in the time sequence that includes the first time.
    Type: Application
    Filed: February 7, 2019
    Publication date: June 6, 2019
    Applicant: SZ DJI TECHNOLOGY CO., LTD.
    Inventors: Sheldon SCHWARTZ, Tao Wang, Mingyu Wang, Zisheng Cao
  • Patent number: 10310660
    Abstract: A hover controlling device includes a sensing unit and a hover control unit. The sensing unit includes a plurality of first electrostatic sensing elements, a plurality of first electrodes, a plurality of second electrostatic sensing elements, and a plurality of third electrodes located on a substrate. Each first electrostatic sensing element and each second electrostatic sensing element include a single walled carbon nanotube or a few-walled carbon nanotube. The resistances of the plurality of first electrostatic sensing elements and the plurality of second electrostatic sensing elements are changed in process of a sensed object with electrostatic near, but does not touch the plurality of first electrostatic sensing elements and the plurality of second electrostatic sensing elements. The hover control unit is electrically connected to the plurality of first electrostatic sensing elements and the plurality of second electrostatic sensing elements.
    Type: Grant
    Filed: December 27, 2015
    Date of Patent: June 4, 2019
    Assignees: Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Xin-He Wang, Dong-Qi Li, Jiang-Tao Wang, Wen-Yun Wu, Yu-Jun He, Peng Liu, Qing-Yu Zhao, Kai-Li Jiang, Shou-Shan Fan
  • Patent number: 10314178
    Abstract: A package module includes a circuit board, an electronic component disposed on the circuit board, a frame disposed next to at least one side of the electronic component, and an encapsulant. A gap is formed between the frame and the electronic component. The encapsulant includes a first portion covering at least a part of the circuit board, and a second portion filling into at least a part of the gap. The first portion has a first height relative to the circuit board, and the second portion has a second height relative to the circuit board, in which the second height is greater than the first height.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: June 4, 2019
    Assignee: DELTA ELECTRONICS (SHANGHAI) CO., LTD.
    Inventors: Hai-Bin Xu, Tao Wang, Shou-Yu Hong, Zhen-Qing Zhao
  • Patent number: 10311128
    Abstract: A computing device computes a quantile value. A maximum value and a minimum value are computed for unsorted variable values to compute an upper bin value and a lower bin value for each bin of a plurality of bins. A frequency counter is computed for each bin by reading the unsorted variable values a second time. A bin number and a cumulative rank value are computed for a quantile. When an estimated memory usage value exceeds a predefined memory size constraint value, a subset of the plurality of bins are split into a plurality of bins, the frequency counter is recomputed for each bin, and the bin number and the cumulative rank value are recomputed. Frequency data is computed using the frequency counters. The quantile value is computed using the frequency data and the cumulative rank value for the quantile and output.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: June 4, 2019
    Assignee: SAS INSTITUTE INC.
    Inventors: Xinmin Wu, Xiangqian Hu, Tao Wang, Xunlei Wu
  • Patent number: 10310163
    Abstract: A display panel and a display device are disclosed. The display panel comprises: a display substrate, an optical substrate, a light guide plate and a first frame; wherein: the optical substrate is arranged between the display substrate and the light guide plate, and the first frame is arranged on the same side edge of the display substrate, the optical substrate and the light guide plate; the light guide plate comprises a first portion and a second portion, wherein the second portion is formed by the first portion extending to the first frame from a side close the first frame, and the distance between the second portion and the first frame is smaller than the thickness of the light guide plate.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: June 4, 2019
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., BOE OPTICAL SCIENCE AND TECHONOLOGY CO., LTD.
    Inventors: Tao Wang, Chunming Wu
  • Patent number: 10310661
    Abstract: A hover controlling device includes a sensing unit and a hover control unit. The sensing unit includes a plurality of first electrostatic sensing elements, a plurality of first electrodes, a plurality of second electrostatic sensing elements, and a plurality of third electrodes located on a substrate. Each first electrostatic sensing element and each second electrostatic sensing element include a single walled carbon nanotube or a few-walled carbon nanotube. The resistances of the plurality of first electrostatic sensing elements and the plurality of second electrostatic sensing elements are changed in process of a sensed object with electrostatic near, but does not touch the plurality of first electrostatic sensing elements and the plurality of second electrostatic sensing elements. The hover control unit is electrically connected to the plurality of first electrostatic sensing elements and the plurality of second electrostatic sensing elements.
    Type: Grant
    Filed: December 27, 2015
    Date of Patent: June 4, 2019
    Assignees: Tsinghua University, HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Xin-He Wang, Dong-Qi Li, Jiang-Tao Wang, Wen-Yun Wu, Yu-Jun He, Peng Liu, Qing-Yu Zhao, Kai-Li Jiang, Shou-Shan Fan
  • Patent number: 10308714
    Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: June 4, 2019
    Assignee: Bristol-Myers Squibb Company
    Inventors: John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton
  • Publication number: 20190163176
    Abstract: One variation of a method for transferring control of an autonomous vehicle to a remote operator includes: accessing a specification for triggering manual control of autonomous vehicles; identifying a road segment, within a geographic region, exhibiting characteristics defined by the specification; and associating a location of the road segment, represented in a navigation map, with a remote operator trigger. The method also includes, at the autonomous vehicle operating within the geographic region: autonomously navigating along a route; transmitting a request for manual assistance to the remote operator in response to approaching the location associated with the remote operator trigger; transmitting sensor data to a remote operator portal associated with the remote operator; and executing a navigational command received from the remote operator via the remote operator portal; and resuming autonomous navigation along the route after passing the location.
    Type: Application
    Filed: November 30, 2018
    Publication date: May 30, 2019
    Inventors: Tao Wang, Wei Song
  • Publication number: 20190154211
    Abstract: Various embodiments may relate to a lighting device, which includes a lamp tube having two open ends, a light engine arranged in the lamp tube, a carrier supporting the light engine, and two end caps closing the open ends. The lighting device further includes a diffuser. The carrier supporting the light engine is held on the diffuser, and the diffuser is held on the inner wall of the lamp tube.
    Type: Application
    Filed: January 28, 2019
    Publication date: May 23, 2019
    Inventors: Dezhao Zhang, Jun Liu, Moritz Engl, Ming Tao Wang
  • Publication number: 20190152970
    Abstract: Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula I structure: and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such estrogen receptor modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 23, 2019
    Applicant: Genentech, Inc.
    Inventors: Sharada LABADIE, Jun Li, Jun Liang, Daniel Fred Ortwine, Xiaojing Wang, Jason Zbieg, Birong Zhang, Nicholas Charles Ray, Simon Goodacre, Zhiguo Liu, Tao Wang
  • Publication number: 20190152957
    Abstract: Disclosed are compounds of Formula I, including pharmaceutically acceptable salts, pharmaceutical compositions comprising the compounds, methods for making the compounds and their use in inhibiting HIV integrase and treating those infected with HIV or AIDS.
    Type: Application
    Filed: May 9, 2017
    Publication date: May 23, 2019
    Inventors: John F. KADOW, B. Narasimhulu NAIDU, Tao WANG, Zhongxing ZHANG
  • Publication number: 20190153099
    Abstract: The disclosure provides a method for immunotherapy of a subject afflicted with cancer, comprises administering to the subject a composition comprising a therapeutically effective amount of an antibody that inhibits signaling from the PD-1/PD-L1 signaling pathway. This disclosure also provides a method for immunotherapy of a subject afflicted with cancer comprising selecting a subject that is a suitable candidate for immunotherapy based on an assessment that the proportion of cells in a test tissue sample from the subject that express PD-L1 on the cell surface exceeds a predetermined threshold level, and administering a therapeutically effective amount of an anti-PD-1 antibody to the selected subject. The invention additionally provides rabbit mAbs that bind specifically to a cell surface-expressed PD-L1 antigen in a FFPE tissue sample, and an automated IHC method for assessing cell surface expression in FFPE tissues using the provided anti-PD-L1 Abs.
    Type: Application
    Filed: January 15, 2019
    Publication date: May 23, 2019
    Applicant: Bristol-Myers Squibb Company
    Inventors: John P. COGSWELL, Stacie M. Goldberg, Ashok K. Gupta, Maria Jure-Kunkel, Xi-Tao Wang, Jon M. Wigginton